Clinical Trial Update: Trial to Evaluate Parenteral Treprostinil and Riociguat on Right Ventriculo-vascular Coupling and Morphology in Those With Advanced PAH [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating parenteral treprostinil and riociguat on right ventriculo-vascular coupling and morphology in advanced pulmonary arterial hypertension …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Adempas (riociguat)
• Remodulin (treprostinil)

Snippet

Sponsor: University of Arizona | Conditions: Pulmonary Arterial Hypertension | Phase 3 | Status: RECRUITING